RxDoctor Payments Data

Francis Jamilla, MD

Critical Care Medicine · Palos Park, ILNPI 1316938897

Payments from drug & device makers

$1,884in general payments, 2019–2025

Across 122 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Boehringer Ingelheim$141
  • Electromed, Inc.$85
  • Pulmonx Corporation$78
  • AbbVie$74
  • Ceribell, Inc.$60
  • plus $430 from 16 others

What the payments were for

  • Food & beverage$1,884100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,884 in reported general payments places this provider in the 70th percentile of 281 critical care medicine providers in Illinois.

See all critical care medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$119,453
Medicare patients
271
Services billed
995

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$54,572
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$27,395
Arnuity ElliptaFluticasone Furoate78$23,403
Breo ElliptaFluticasone/Vilanterol36$17,111
Incruse ElliptaUmeclidinium Bromide43$16,396
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,341
Albuterol Sulfate HfaAlbuterol Sulfate51$1,544
Montelukast Sodium39$396
Azithromycin24$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta$1,016$138,877223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 281 critical care medicine providers in Illinois.

Other critical care medicine in Palos Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →